• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素刺激基因和 IL-28B 的遗传变异作为慢性丙型肝炎联合治疗反应的宿主预后因素。

Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.

机构信息

Liver Unit, Gastroenterology Service, Hospital Universitario de La Princesa, Instituto de Investigación Sanitario Princesa, Universidad Autónoma de Madrid, Madrid, Spain.

出版信息

Clin Pharmacol Ther. 2011 Nov;90(5):712-21. doi: 10.1038/clpt.2011.189. Epub 2011 Oct 12.

DOI:10.1038/clpt.2011.189
PMID:21993426
Abstract

Chronic hepatitis C (CHC) is a worldwide health problem that is highly related to liver fibrosis, cirrhosis, and hepatocellular carcinoma. The achievement of response to the current standard of care-pegylated interferon plus ribavirin-has recently been described to be associated with single-nucleotide polymorphisms (SNPs) near the IL-28B gene. Additionally, baseline expression levels of genes involved in interferon (IFN)-stimulated genes (ISGs) have been found to be related to treatment outcome. In the present study, 285 patients were genotyped for 63 SNPs within genes of the IFN signaling pathway (IPGs) and ISGs. Two ISG polymorphisms-OASL rs12819210 (odds ratio (OR)=2.1, P=0.03) and IFIT1 rs304478 (OR=2.5, P=0.01)-were found to be independent predictive factors of sustained virological response (SVR) after adjusting for other clinical covariates. Furthermore, the predictive value of IL-28B SNP was notably improved by simultaneous genotyping of rs12819210 and rs304478, particularly in patients with the worst prognosis (viral genotype 1, area under the curve (AUC)=0.74). In conclusion, ISG SNPs could constitute a valuable tool for individualizing CHC therapy.

摘要

慢性丙型肝炎(CHC)是一个全球性的健康问题,与肝纤维化、肝硬化和肝细胞癌高度相关。最近发现,对当前标准治疗-聚乙二醇干扰素加利巴韦林的反应与 IL-28B 基因附近的单核苷酸多态性(SNPs)有关。此外,干扰素(IFN)刺激基因(ISGs)相关基因的基线表达水平也与治疗结果有关。在本研究中,对 285 例患者进行了 IFN 信号通路(IPGs)和 ISGs 中 63 个 SNPs 的基因分型。两个 ISG 多态性-OASL rs12819210(比值比(OR)=2.1,P=0.03)和 IFIT1 rs304478(OR=2.5,P=0.01)-被发现是持续病毒学应答(SVR)的独立预测因素,在调整其他临床协变量后。此外,IL-28B SNP 的预测价值通过同时对 rs12819210 和 rs304478 进行基因分型得到显著改善,特别是在预后最差的患者中(病毒基因型 1,曲线下面积(AUC)=0.74)。总之,ISG SNPs 可以成为个体化 CHC 治疗的有价值的工具。

相似文献

1
Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.干扰素刺激基因和 IL-28B 的遗传变异作为慢性丙型肝炎联合治疗反应的宿主预后因素。
Clin Pharmacol Ther. 2011 Nov;90(5):712-21. doi: 10.1038/clpt.2011.189. Epub 2011 Oct 12.
2
[PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].[血型特异性与白细胞介素28B基因多态性联合检测对预测聚乙二醇化干扰素α-2与利巴韦林治疗慢性基因1型丙型肝炎患者疗效的价值]
Klin Med (Mosk). 2016;94(3):224-30.
3
Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.肝组织干扰素刺激基因表达与白细胞介素 28B 基因多态性及慢性丙型肝炎干扰素治疗结局相关。
Gastroenterology. 2010 Aug;139(2):499-509. doi: 10.1053/j.gastro.2010.04.049. Epub 2010 Apr 29.
4
Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.干扰素信号通路基因和干扰素刺激基因中的单核苷酸多态性与慢性丙型肝炎干扰素治疗反应的关联
J Hepatol. 2008 Aug;49(2):184-91. doi: 10.1016/j.jhep.2008.04.011. Epub 2008 May 20.
5
Prevalence of rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.rs4803217单核苷酸多态性的患病率与慢性丙型肝炎的临床病程
World J Gastroenterol. 2017 Jun 7;23(21):3815-3824. doi: 10.3748/wjg.v23.i21.3815.
6
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.宿主遗传 IL-28B 变异在聚乙二醇干扰素联合利巴韦林治疗复发的亚洲丙型肝炎病毒 1 型患者中的临床应用。
J Gastroenterol Hepatol. 2013 Sep;28(9):1515-20. doi: 10.1111/jgh.12211.
7
Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.聚乙二醇干扰素α和利巴韦林治疗的慢性丙型肝炎患者的持续病毒学应答与IL28B单核苷酸多态性
Acta Biochim Pol. 2012;59(3):333-7. Epub 2012 Aug 27.
8
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.聚乙二醇干扰素 α 联合利巴韦林治疗慢性丙型肝炎 1 型复发患者中白细胞介素-28B 基因多态性对再治疗结局的价值。
J Gastroenterol Hepatol. 2014 Jan;29(1):102-9. doi: 10.1111/jgh.12329.
9
Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.预测慢性丙型肝炎治疗反应:一种结合白细胞介素-28B 基因多态性和临床数据的方法。
J Gastroenterol Hepatol. 2012 Feb;27(2):279-85. doi: 10.1111/j.1440-1746.2011.06834.x.
10
Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.埃及慢性丙型肝炎病毒基因 4 型患者白细胞介素-10 和白细胞介素-28B 基因多态性及其对聚乙二醇干扰素/利巴韦林治疗反应的影响。
J Gastroenterol Hepatol. 2012 Dec;27(12):1842-9. doi: 10.1111/j.1440-1746.2012.07273.x.

引用本文的文献

1
Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment.干扰素刺激基因 OASL 的多组学全景揭示了一种潜在的泛癌生物标志物:从预后到肿瘤微环境。
Front Immunol. 2024 Sep 2;15:1402951. doi: 10.3389/fimmu.2024.1402951. eCollection 2024.
2
Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis.先天免疫基因的遗传多态性影响蜱传脑炎的易感性。
J Neurovirol. 2023 Dec;29(6):699-705. doi: 10.1007/s13365-023-01182-8. Epub 2023 Oct 28.
3
The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.
白细胞介素28B基因多态性对HBV或HCV感染患者肝细胞癌风险的影响:一项更新的荟萃分析。
Medicine (Baltimore). 2019 Sep;98(38):e17275. doi: 10.1097/MD.0000000000017275.
4
Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C.慢性丙型肝炎坏死性炎症活动的干扰素相关基因标志物。
PLoS One. 2017 Jul 12;12(7):e0180927. doi: 10.1371/journal.pone.0180927. eCollection 2017.
5
polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection.多态性可预测α干扰素治疗乙型肝炎病毒感染的疗效。
World J Gastroenterol. 2016 Nov 28;22(44):9813-9821. doi: 10.3748/wjg.v22.i44.9813.
6
Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.白细胞介素28B基因多态性作为慢性丙型肝炎持续病毒学应答的预测指标:系统评价与荟萃分析
Pharmacogenomics J. 2016 Feb;16(1):18-29. doi: 10.1038/tpj.2015.28. Epub 2015 Apr 28.
7
Interferon-induced Ifit proteins: their role in viral pathogenesis.干扰素诱导的Ifit蛋白:它们在病毒发病机制中的作用。
J Virol. 2015 Mar;89(5):2462-8. doi: 10.1128/JVI.02744-14. Epub 2014 Nov 26.
8
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.丙型肝炎病毒治疗结果中杀伤细胞免疫球蛋白样受体(KIR)基因型和KIR2DL2/3变体的多样性。
PLoS One. 2014 Jun 13;9(6):e99426. doi: 10.1371/journal.pone.0099426. eCollection 2014.
9
Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.丙型肝炎感染的个体化治疗:聚焦于白细胞介素 28B 多态性指导治疗。
Mol Diagn Ther. 2014 Feb;18(1):25-38. doi: 10.1007/s40291-013-0053-4.
10
Interferon induced IFIT family genes in host antiviral defense.干扰素诱导的 IFIT 家族基因在宿主抗病毒防御中。
Int J Biol Sci. 2013;9(2):200-8. doi: 10.7150/ijbs.5613. Epub 2013 Feb 11.